0      0

2021 Advanced Heart Failure Symposium

A-18 - New FDA Approved Thearpies


Oct 8, 2021 4:30pm ‐ Oct 8, 2021 5:00pm


Learning Objective:
  • 1. Discuss the evidence for the use of SGLT2 inhibitors in the management of heart failure 2. Review the clinical evidence for the use of soluble guanylate cyclase stimulator in the management of heart failure 3. Describe therapies on the horizon in clinical trial for heart failure

Speaker(s):

You must be logged in and own this session in order to post comments.